[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336320-105":59,"doc-detail-336320-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","advances-in-combined-neuroendocrine-carcinoma-of-lung-cancer-mini-review-2024","Advances in combined neuroendocrine carcinoma of lung cancer - Mini Review - 2024","","Lung cancer incidence and mortality continue to rise globally, creating major public health pressure and family burden. This mini review focuses on combined pulmonary carcinomas with a neuroendocrine component, summarizing the major clinicopathological subtypes and illustrating distinctive pathological patterns. It reviews global classification frameworks, discusses the emergence of combined neuroendocrine forms, and explains key mechanisms behind small-cell neuroendocrine transformation from adenocarcinoma after targeted therapies. The review also outlines biomarker-based detection and highlights the need for individualized treatment strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/advances-in-combined-neuroendocrine-carcinoma-of-lung-cancer-mini-review-2024/336320/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/advances-in-combined-neuroendocrine-carcinoma-of-lung-cancer-mini-review-2024/336320.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the review primarily focus on?","Question",{"text":112,"@type":113},"The review focuses on combined pulmonary carcinomas that contain a neuroendocrine component, summarizing their key pathological and clinical subtypes and providing illustrative pathological images.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are neuroendocrine tumors classified in the context discussed?",{"text":117,"@type":113},"Neuroendocrine tumors are described as being divided into typical carcinoid, atypical carcinoid, small-cell carcinoma, and large-cell neuroendocrine carcinoma based on combined features.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanisms are proposed for small-cell transformation from adenocarcinoma?",{"text":121,"@type":113},"Proposed mechanisms include resistance to EGFR/ALK/ROS1 tyrosine kinase inhibitors or immunotherapies, with examples such as EGFR T790M mutation, MET amplification, EGFR amplification, and PIK3CA-related changes associated with epithelial-to-mesenchymal transition.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336320,1790704841,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","TYPE Mini Review  \nPUBLISHED 14 May 2024  \nDOI 10.3389/pore.2024.1611693  \nOPEN ACCESS  \nEDITED BY  \nGabriella Galffy,  \nTörökbálint Pulmonology Hospital, Hungary  \n*CORRESPONDENCE  \nZesen Han,  \n [hanzesen908@163.com](hanzesen908@163.com)[ ](hanzesen908@163.com)Fenglei Li,  \n lﬂ[huayi@126.com](huayi@126.com)  \nRECEIVED 19 January 2024  \nACCEPTED 29 April 2024  \nPUBLISHED 14 May 2024  \nCITATION  \nHan Z, Yang F, Wang F, Zheng H, Chen X, Meng H and Li F (2024), Advances in combined neuroendocrine carcinoma of lung cancer.  \nPathol. Oncol. Res. 30:1611693 .  \ndoi: 10.3389/pore.2024.1611693  \nCOPYRIGHT  \n© 2024 Han, Yang, Wang, Zheng, Chen, Meng and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nAdvances in combined neuroendocrine carcinoma of lung cancer  \nZesen Han 1*, Fujun Yang 2, Fang Wang 1, Huayu Zheng 1, Xiujian Chen 1, Hongyu Meng 1 and Fenglei Li 1*  \n1Hua Country People ’s Hospital, Anyang, Henan, China, 2Department of Medical Oncology, Sanmenxia Central Hospital, Henan University of Science and Technology, Sanmenxia, China  \nLung cancer incidence and mortality rates are increasing worldwide, posing asigniﬁcant public health challenge and an immense burden to affected families. Lung cancer encompasses distinct subtypes, namely, non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC) . In clinical investigations, researchers have observed that neuroendocrine tumors can be classiﬁed into four types: typical carcinoid, atypical carcinoid, small-cell carcinoma, and largecell neuroendocrine carcinoma based on their unique features. However, there exist combined forms of neuroendocrine cancer. This study focuses speciﬁcallyon combined pulmonary carcinomas with a neuroendocrine component. In this comprehensive review article, the authors provide an overview of combined lung cancers and present two pathological images to visually depict these distinctive subtypes.  \nKEYWORDS  \nsmall cell neuroendocrine carcinoma, large cell neuroendocrine carcinoma, adenocarcinoma, squamous cell carcinoma, lung cancer  \nIntroduction  \nGlobally, the morbidity and mortality rates of lung cancer are increasing [1], making ita signiﬁcant public health concern and burden for families [2] . Approximately 75% of the 2.20 million newly diagnosed lung cancer patients will succumb to the disease within 5 years [3–5]. Lung cancer comprises distinct subtypes, such as non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC) . The mortality rate of NSCLC has been shown to improve from 2013 to 2016 following diagnosis [6], due to advances in screening, early patient management, immunotherapy, and other interventions [7] . However, SCLC remains challenging due to its propensity for relapse and higher mortality rates accounting for up to 15% of all lung cancers [8] . Despite decades of research focused on targeted treatments based on biomarker selection and immunotherapy, SCLC continues to be one of the most difﬁcult-to-treat tumorigenic diseases [9] .  \nIn 2021, the WHO classiﬁed the lung tumors since 2015 [10] into ﬁve categories: 1) Small cell carcinoma, 2) Large cell neuroendocrine carcinoma, 3) Adenosquamous carcinoma (if both components ≥ 10%), 4) Adenocarcinoma, squamous cell  \nPathology & Oncology Research 01 Published by Frontiers  \ncarcinoma, adenosquamous carcinoma, or large cell carcinoma with unclear immunohistochemical features, 5) Pleomorphic, spindle cell, and/or giant cell carcinoma for the resection specimens. However, in clinical work, researchers have observed an additional subtype. In pathology studies, neuroendocr","cbCaifxWfn9ZrSJv","https://ap.wps.com/l/cbCaifxWfn9ZrSJv","pdf",2322513,"English","# Introduction\n# Classification and additional neuroendocrine subtypes\n# Combined small cell neuroendocrine carcinoma with adenocarcinoma","[{\"question\":\"What does the review primarily focus on?\",\"answer\":\"The review focuses on combined pulmonary carcinomas that contain a neuroendocrine component, summarizing their key pathological and clinical subtypes and providing illustrative pathological images.\"},{\"question\":\"How are neuroendocrine tumors classified in the context discussed?\",\"answer\":\"Neuroendocrine tumors are described as being divided into typical carcinoid, atypical carcinoid, small-cell carcinoma, and large-cell neuroendocrine carcinoma based on combined features.\"},{\"question\":\"What mechanisms are proposed for small-cell transformation from adenocarcinoma?\",\"answer\":\"Proposed mechanisms include resistance to EGFR/ALK/ROS1 tyrosine kinase inhibitors or immunotherapies, with examples such as EGFR T790M mutation, MET amplification, EGFR amplification, and PIK3CA-related changes associated with epithelial-to-mesenchymal transition.\"}]","Advances in combined neuroendocrine carcinoma of lung cancer - Mini Review - 2024 | PDF",1790014515,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45f351f0c46e3494852453f11958e5d2.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee07bc00c1aa792bfe04817853a694d3.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0aed685c2f4fee6b14a95f55e0981d87.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d2536db069b47298740c584debaefa3.webp",980,1385]